RESTOR: PK/PD mTORi Inhibition in Older Adults

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

194

Participants

Timeline

Start Date

August 13, 2025

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions

Aging

Interventions

DRUG

Rapamycin

mTOR inhibitor

DRUG

Everolimus

mTOR inhibitor

OTHER

Placebo

Inert placebo for rapamycin or everolimus

Trial Locations (1)

RECRUITING

The University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors

collaborator

National Institute on Aging (NIA)

NIH

lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT06658093 - RESTOR: PK/PD mTORi Inhibition in Older Adults | Biotech Hunter | Biotech Hunter